Clinical Trial

Nutrition Intervention Combined With Resmetirom for MASH

Study acronym: NOURISH-MASH
Not Yet Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
This randomized control trial aims to evaluate the effectiveness of combining resmetirom therapy (first approved pharmacological therapy for treating metabolic dysfunction-associated steatohepatitis (MASH)) with a nutritional intervention compared to resmetirom therapy alone over one year in improving liver health among 120 patients living with non-cirrhotic MASH. We hypothesize that patients receiving resmetirom and nutritional intervention will experience more significant improvements in liver function than those receiving only resmetirom therapy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2026-06-25.
Trial Details
NCT Number NCT07680478
Lead Sponsor City University of New York
Conditions Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Enrollment 120 participants
Start Date 2026-10-01
Primary Completion 2028-02-28 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-06